| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 7629745
[patent_doc_number] => 06818611
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-16
[patent_title] => 'Stabilized bioactive peptides and methods of identification, synthesis and use'
[patent_app_type] => B1
[patent_app_number] => 09/701947
[patent_app_country] => US
[patent_app_date] => 2000-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 27924
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/818/06818611.pdf
[firstpage_image] =>[orig_patent_app_number] => 09701947
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/701947 | Stabilized bioactive peptides and methods of identification, synthesis and use | Dec 4, 2000 | Issued |
Array
(
[id] => 1034533
[patent_doc_number] => 06875743
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-04-05
[patent_title] => 'Cell adhesion inhibitors'
[patent_app_type] => utility
[patent_app_number] => 09/724139
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22646
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 326
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/875/06875743.pdf
[firstpage_image] =>[orig_patent_app_number] => 09724139
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/724139 | Cell adhesion inhibitors | Nov 27, 2000 | Issued |
| 09/709700 | Animal collagens and gelatins | Nov 9, 2000 | Abandoned |
| 09/674923 | Cyclosporin preparations | Nov 7, 2000 | Abandoned |
Array
(
[id] => 985633
[patent_doc_number] => 06924363
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-08-02
[patent_title] => 'Oil bodies and associated proteins as affinity matrices'
[patent_app_type] => utility
[patent_app_number] => 09/707167
[patent_app_country] => US
[patent_app_date] => 2000-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 24
[patent_no_of_words] => 18797
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/924/06924363.pdf
[firstpage_image] =>[orig_patent_app_number] => 09707167
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/707167 | Oil bodies and associated proteins as affinity matrices | Nov 6, 2000 | Issued |
Array
(
[id] => 1105186
[patent_doc_number] => 06812203
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-02
[patent_title] => 'CD40-Interacting and TRAF-interacting proteins'
[patent_app_type] => B1
[patent_app_number] => 09/697863
[patent_app_country] => US
[patent_app_date] => 2000-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13994
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/812/06812203.pdf
[firstpage_image] =>[orig_patent_app_number] => 09697863
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/697863 | CD40-Interacting and TRAF-interacting proteins | Oct 26, 2000 | Issued |
Array
(
[id] => 1131582
[patent_doc_number] => 06787641
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-07
[patent_title] => 'Identification of sel-12 and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/043944
[patent_app_country] => US
[patent_app_date] => 2000-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 23357
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/787/06787641.pdf
[firstpage_image] =>[orig_patent_app_number] => 09043944
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/043944 | Identification of sel-12 and uses thereof | Oct 5, 2000 | Issued |
Array
(
[id] => 766728
[patent_doc_number] => 07009042
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-03-07
[patent_title] => 'Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins'
[patent_app_type] => utility
[patent_app_number] => 09/684215
[patent_app_country] => US
[patent_app_date] => 2000-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 9753
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/009/07009042.pdf
[firstpage_image] =>[orig_patent_app_number] => 09684215
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/684215 | Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins | Oct 5, 2000 | Issued |
Array
(
[id] => 1046840
[patent_doc_number] => 06864235
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-08
[patent_title] => 'Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans'
[patent_app_type] => utility
[patent_app_number] => 09/685010
[patent_app_country] => US
[patent_app_date] => 2000-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 91
[patent_no_of_words] => 42882
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/864/06864235.pdf
[firstpage_image] =>[orig_patent_app_number] => 09685010
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/685010 | Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans | Oct 4, 2000 | Issued |
Array
(
[id] => 1245129
[patent_doc_number] => 06676947
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-13
[patent_title] => 'Use of erythropoietin for the treatment of haemochromatoses'
[patent_app_type] => B1
[patent_app_number] => 09/647642
[patent_app_country] => US
[patent_app_date] => 2000-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4306
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/676/06676947.pdf
[firstpage_image] =>[orig_patent_app_number] => 09647642
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/647642 | Use of erythropoietin for the treatment of haemochromatoses | Oct 2, 2000 | Issued |
| 09/646778 | Human nucleic acid sequences from ovarian tumour tissue | Sep 21, 2000 | Abandoned |
Array
(
[id] => 7617001
[patent_doc_number] => 06946440
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-09-20
[patent_title] => 'Composition for stabilizing corneal tissue during or after orthokeratology lens wear'
[patent_app_type] => utility
[patent_app_number] => 10/088032
[patent_app_country] => US
[patent_app_date] => 2000-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7801
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/946/06946440.pdf
[firstpage_image] =>[orig_patent_app_number] => 10088032
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/088032 | Composition for stabilizing corneal tissue during or after orthokeratology lens wear | Sep 14, 2000 | Issued |
Array
(
[id] => 1337193
[patent_doc_number] => 06593293
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-15
[patent_title] => 'Lepidopteran-active Bacillus thuringiensis -endotoxin compositions and methods of use'
[patent_app_type] => B1
[patent_app_number] => 09/661322
[patent_app_country] => US
[patent_app_date] => 2000-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66380
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/593/06593293.pdf
[firstpage_image] =>[orig_patent_app_number] => 09661322
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/661322 | Lepidopteran-active Bacillus thuringiensis -endotoxin compositions and methods of use | Sep 12, 2000 | Issued |
| 09/658603 | Gamma-Carboxyglutamate containing conopeptides | Sep 7, 2000 | Abandoned |
| 09/645961 | Kidney-specific protein | Aug 23, 2000 | Abandoned |
Array
(
[id] => 1246254
[patent_doc_number] => 06677440
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-13
[patent_title] => 'Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or a mixture of both proteins by means of ion-exchange chromatography'
[patent_app_type] => B1
[patent_app_number] => 09/632627
[patent_app_country] => US
[patent_app_date] => 2000-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3449
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/677/06677440.pdf
[firstpage_image] =>[orig_patent_app_number] => 09632627
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/632627 | Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or a mixture of both proteins by means of ion-exchange chromatography | Aug 3, 2000 | Issued |
Array
(
[id] => 1253794
[patent_doc_number] => 06670455
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-30
[patent_title] => 'Process for the preparation in pure form of the protease activating blood clotting VII, its proenzyme or a mixture of both proteins by means of affinity chromatography'
[patent_app_type] => B1
[patent_app_number] => 09/632974
[patent_app_country] => US
[patent_app_date] => 2000-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2619
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/670/06670455.pdf
[firstpage_image] =>[orig_patent_app_number] => 09632974
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/632974 | Process for the preparation in pure form of the protease activating blood clotting VII, its proenzyme or a mixture of both proteins by means of affinity chromatography | Aug 3, 2000 | Issued |
Array
(
[id] => 715807
[patent_doc_number] => 07053042
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-05-30
[patent_title] => 'Activation of peptide prodrugs by hK2'
[patent_app_type] => utility
[patent_app_number] => 09/627600
[patent_app_country] => US
[patent_app_date] => 2000-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9494
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/053/07053042.pdf
[firstpage_image] =>[orig_patent_app_number] => 09627600
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/627600 | Activation of peptide prodrugs by hK2 | Jul 27, 2000 | Issued |
Array
(
[id] => 707844
[patent_doc_number] => 07060671
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-06-13
[patent_title] => 'Peptides containing N-substituted D-amino acids for preventing β-strand association'
[patent_app_type] => utility
[patent_app_number] => 10/030138
[patent_app_country] => US
[patent_app_date] => 2000-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 16209
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 246
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/060/07060671.pdf
[firstpage_image] =>[orig_patent_app_number] => 10030138
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/030138 | Peptides containing N-substituted D-amino acids for preventing β-strand association | Jul 27, 2000 | Issued |
Array
(
[id] => 637885
[patent_doc_number] => 07125838
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-10-24
[patent_title] => 'Peptides containing N-substituted L-amino acids for preventing β-strand association'
[patent_app_type] => utility
[patent_app_number] => 10/030137
[patent_app_country] => US
[patent_app_date] => 2000-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 16499
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 261
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/125/07125838.pdf
[firstpage_image] =>[orig_patent_app_number] => 10030137
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/030137 | Peptides containing N-substituted L-amino acids for preventing β-strand association | Jul 27, 2000 | Issued |